David vs. Goliath? — VB ThinkShare Salon Episode 6 Explores China's Booming Pharma M&A Market

"Listen to in-depth insights from senior investment and M&A experts,"
Reflections on the Rapid Growth of China’s Pharmaceutical Investment and M&A Market
675 billion–124.13 billion

From a scale of hundreds of billions to trillions, the Chinese pharmaceutical market took less than four years, with a compound annual growth rate (CAGR) as high as 16.5%.
Market estimates suggest that China is poised to become the world's second-largest pharmaceutical market this year.

Amid the rapid growth of the pharmaceutical market, mergers and acquisitions (M&A) and consolidation among pharmaceutical companies have remained highly active. According to incomplete statistics based on announcements by companies listed on the Shanghai and Shenzhen stock exchanges and publicly available information, from January 2014 to May 25, 2015, there were 244 M&A transactions, with a total value reaching RMB 60 billion, averaging nearly one M&A announcement per trading day.

What market developments and transformations are signaled by such frequent and high-value mergers and acquisitions? How should pharmaceutical companies caught in the whirlwind position themselves for growth? And what role does the internet play in this landscape?

Let us join the 6th Thought Sharing Salon, co-hosted by VCBeat and Hejun Pharmaceutical Salon:

Time: 19:00, Thursday, July 2, 2015
Location: Beijing (specific venue to be determined; uniform notification will be issued upon approval of registration)
Salon Format: Thematic Sharing
Guest Speaker: Dr. Zhang Ziran

Mastering the Art of M&A, Pondering the Path of Investment — Dr. Nature

Zhang Ziran, Vice President of the China Association of Traditional Chinese Medicine, concurrently serves as Vice President of the China Non-prescription Pharmaceutical Association, Vice President of the Professional Committee on Chinese Materia Medica Pharmaceutics of the World Federation of Chinese Medicine Societies, and Review Expert at the Drug Price Evaluation Center of the National Development and Reform Commission. He studied in the United Kingdom and worked in the pharmaceutical industry in the United States. He has held leadership roles in marketing and mergers and acquisitions at Hainan Hailing Pharmaceutical, Suzhou Dongrui Pharmaceutical, Shanghai Pharmaceuticals Group, and Shineway Pharmaceutical Group. He has cultivated numerous well-known brands and completed multiple large-scale mergers and acquisitions of pharmaceutical enterprises. As a seasoned expert in pharmaceutical operations and M&A, he is also the Editor-in-Chief of Theory and Practice of Modern Physical Pharmacy.
We welcome all industry leaders in pharmaceutical and hospital investment and M&A to attend with a small fee.

Registration Method:

1. Follow the VCBeat official account (search for VCBEAT or VCBeat)
2. Reply: Name + Phone Number + Email Address + Company + Job Title + "Si Xiang Hui Salon" to the official WeChat account

Editor’s Note:

To avoid a recurrence of the overcrowding seen in the 5th Si Xiang Hui session, this salon event is limited to 50 participants.
Deadline: 12:00 PM, July 2
Additionally, a service fee of 50 yuan is required for this event, which includes refreshments and fruit.

Themes of the First Five VCBeat VB Think Tank Salon Sessions:

1、Spring Rain Doctor Data Full Interpretation Report Sharing Session:A Detailed Analysis of Chunyu Yisheng’s Data Report: Statistical Review of Q4 Data and Reassessment of Development Trends
2、Vesalius Ventures Shares U.S. Mobile Health Investment Philosophy and Success Stories: Invited Lu Jun, Vice President of Vesalius Ventures and Managing Partner for China, to share his venture capital firm’s investment practices in the healthcare sector.

3、In-Depth Interpretation of HIPAA: We have invited Zhao Xinyuan, a leading expert in China’s healthcare informatics sector, to provide a detailed interpretation of the nuances of HIPAA regulations.

4、From Surface to Core: Hear How Top International Enterprises, Physicians, and Investors Are Embracing the Wave of Internet Healthcare。

5、The Convergence of Smart Hardware and Internet Healthcare: JD.com, Alibaba, Huami, Fosun, and other industry leaders share their respective strategic layouts